Skip to main content
V

Vault Ventures PLC — Investor Relations & Filings

Ticker · VULT ISIN · GB00BJDPYD55 LEI · 213800CBZ6E6WRDGV387 Aquis Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 96 across all filing types
Latest filing 2021-12-30 Board/Management Inform…
Country GB United Kingdom
Listing Aquis Stock Exchange VULT

About Vault Ventures PLC

https://vaultplc.com/

Vault Ventures PLC is an emerging technology company that builds and commercializes proprietary products in artificial intelligence (AI), blockchain, and financial technology (fintech). The company focuses on developing agentic AI systems, crypto-native Web3 infrastructure, and innovative fintech solutions. Leveraging its in-house development agency, System7, Vault Ventures combines technical expertise with capital markets experience to create and scale its products. The company's operations are supported by a digital asset treasury function designed to ensure long-term execution and resilience.

Recent filings

Filing Released Lang Actions
Board Changes
Board/Management Information Classification · 1% confidence The document is an official announcement from Pharma C Investments PLC regarding the resignation of a director (Chana Greenberg) and the appointment of an acting CEO (Toby Shillito). This clearly falls under the category of board and management changes.
2021-12-30 English
Pharma C Invests in Product Earth Expo
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Pharma C Investments PLC regarding a new investment in 'Product Earth Expo'. It details the investment amount, the strategic rationale, and mentions it is a related party transaction. Since it is a general regulatory announcement regarding company activity (investment) that does not fit into specific categories like M&A (which usually implies full acquisition or merger) or capital raising (it is an investment *by* the company), it falls under the general regulatory filing category.
2021-11-08 English
Interim Results
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Results' and contains comprehensive unaudited financial statements, including a profit and loss account, balance sheet, statement of changes in equity, and cash flow statement for the six-month period ended 30 June 2021. It provides substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). Although it is distributed via RNS, it is not merely an announcement of a report but the report itself. H1 2021
2021-09-28 English
Board Change and Appointment of Corporate Advisor
Regulatory Filings Classification · 1% confidence The document is an RNS announcement from Pharma C Investments PLC detailing multiple corporate events: a board change (appointment of a new Chief Business Development Officer), the appointment of a new corporate advisor, and the grant of share options and warrants to directors. While it contains elements of 'Board/Management Information' (MANG) and 'Director's Dealing' (DIRS), the document is a comprehensive regulatory announcement covering multiple topics, which is best classified under the 'Regulatory Filings' (RNS) category as it serves as the primary disclosure mechanism for these events.
2021-06-25 English
Admission to AQSE Growth Market and Fundraising
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement regarding the admission of Pharma C Investments PLC to the AQSE Growth Market and the closing of a £1 million fundraising round. It details the company's investment strategy, board composition, and the use of proceeds. Since it describes a capital-raising event and the commencement of trading, it falls under the 'Capital/Financing Update' category.
2021-05-26 English
Intention to List and Proposed Equity Raise
Regulatory Filings Classification · 1% confidence The document is an announcement by Pharma C Investments PLC regarding its intention to list on the Aquis Stock Exchange (AQSE) Growth Market and conduct an equity raise. It outlines the company's business strategy, management team, and the purpose of the fundraising. It is not a prospectus itself, but an announcement of the intent to list and raise capital. This fits the 'Capital/Financing Update' category as it details the company's financing activities and capital structure changes related to the upcoming IPO/listing.
2021-05-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.